Multipotent bone marrow cell-seeded polymeric composites drive long-term, definitive urinary bladder tissue regeneration

• Published in: PNAS nexus Vol. 3; no. 2; p. pgae038
• Main Authors: Bury, Matthew I, Fuller, Natalie J, Wang, Xinlong, Chan, Yvonne Y, Sturm, Renea M, Oh, Sang Su, Sofer, Laurel A, Arora, Hans C, Sharma, Tiffany T, Nolan, Bonnie G, Feng, Wei, Rabizadeh, Rebecca R, Barac, Milica, Edassery, Sonia S, Goedegebuure, Madeleine M, Wang, Larry W, Ganesh, Balaji, Halliday, Lisa C, Seniw, Mark E, Edassery, Seby L, Mahmud, Nadim B, Hofer, Matthias D, McKenna, Kevin E, Cheng, Earl Y, Ameer, Guillermo A, Sharma, Arun K
• Format: Journal Article
• Language: English
• Published: England Oxford University Press 01-02-2024
• Subjects: Bladder; Bone marrow cells; Care and treatment; Health aspects; Methods; Regeneration (Biology); United States; biomechanocompatible scaffold; urinary bladder; autologous stem cells; regenerative engineering
• ISSN: 2752-6542; 2752-6542
• DOI: 10.1093/pnasnexus/pgae038

To date, there are no efficacious translational solutions for end-stage urinary bladder dysfunction. Current surgical strategies, including urinary diversion and bladder augmentation enterocystoplasty (BAE), utilize autologous intestinal segments (e.g. ileum) to increase bladder capacity to protect renal function. Considered the standard of care, BAE is fraught with numerous short- and long-term clinical complications. Previous clinical trials employing tissue engineering approaches for bladder tissue regeneration have also been unable to translate bench-top findings into clinical practice. Major obstacles still persist that need to be overcome in order to advance tissue-engineered products into the clinical arena. These include scaffold/bladder incongruencies, the acquisition and utility of appropriate cells for anatomic and physiologic tissue recapitulation, and the choice of an appropriate animal model for testing. In this study, we demonstrate that the elastomeric, bladder biomechanocompatible poly(1,8-octamethylene-citrate-co-octanol) (PRS; synthetic) scaffold coseeded with autologous bone marrow-derived mesenchymal stem cells and CD34
hematopoietic stem/progenitor cells support robust long-term, functional bladder tissue regeneration within the context of a clinically relevant baboon bladder augmentation model simulating bladder trauma. Partially cystectomized baboons were independently augmented with either autologous ileum or stem-cell-seeded small-intestinal submucosa (SIS; a commercially available biological scaffold) or PRS grafts. Stem-cell synergism promoted functional trilayer bladder tissue regeneration, including whole-graft neurovascularization, in both cell-seeded grafts. However, PRS-augmented animals demonstrated fewer clinical complications and more advantageous tissue characterization metrics compared to ileum and SIS-augmented animals. Two-year study data demonstrate that PRS/stem-cell-seeded grafts drive bladder tissue regeneration and are a suitable alternative to BAE.